Maynard Um
-
-
-
-
-
-
-
Needham Reiterates Buy Rating on Veracyte, Inc (VCYT)
-
-
-
-
-
-
-
Leerink Partners Reiterates Outperform Rating on Veracyte, Inc (VCYT)
-
-
-
-
-
-
-
Veracyte to present prostate cancer biomarker data at ASTRO 2025
-
-
-
-
-
-
-
Scotiabank Reiterates Sector Outperform Rating on Veracyte, Inc (VCYT)
-
-
-
-
-
-
-
Needham Reiterates Buy Rating on Veracyte, Inc (VCYT)
-
-
-
-
-
-
-
Veracyte (VCYT) Tops Q3 EPS by 30c, provides guidance
-
-
-
-
-
-
404,861 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

